Altmetric tracks the shares and mentions of your work across a wide-variety of online sources and collects them into a single, unified display.
The Altmetric “donut” is embedded into each publication in Synapse, allowing MSK authors to easily visualize and link out to the public’s interactions with their research. From within Synapse, click on the donut on the right side of the article and then use the tabs to explore each category in detail.
Take a look at the online attention from these MSK Publications added to Synapse in July 2018:
- Neoadjuvant PD-1 blockade in resectable lung cancer. New England Journal of Medicine. 2018 May 24;378(21):1976-1986.
- Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology. 2018 Jun 10;36(17):1714-1768.
- Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden. New England Journal of Medicine. 2018 May 31;378(22):2093-2104.